Disease | Incidence Estimate | US people estimate | Statistic Used for Calculation |
| Lung conditions (overall) |
N/A |
N/A |
more than 30 million Americans with chronic lung diseases (NWHIC)
|
| Pneumonia |
approx 1 in 56 or 1.76% or 4.8 million people in USA |
4,800,000 |
4.8 million annual cases (1996); 1.8 per 100 (NHIS96)
|
| Lung cancer |
approx 1 in 1,605 or 0.06% or 169,400 people in USA |
169,399 |
169,400 annual cases (SEER 2002 estimate: lung and bronchus cancers)
|
| Bronchopulmonary dysplasia |
approx 1 in 54,400 or 0.00% or 5,000 people in USA |
5,000 |
5,000 to 10,000 new cases
|
| Bronchitis |
N/A |
N/A |
No information
|
| Chronic Bronchitis |
N/A |
N/A |
No information
|
| Emphysema |
N/A |
N/A |
No information
|
| COPD |
N/A |
N/A |
No information
|
| Cystic fibrosis |
approx 1 in 108,800 or 0.00% or 2,500 people in USA |
2,500 |
2,500 babies annually USA; 1 in 3,000 Caucasian babies
|
| bronchiectasis |
N/A |
N/A |
No information
|
| Asthma |
N/A |
N/A |
No information
|
| bronchiolitis |
N/A |
N/A |
No information
|
| bronchiolitis obliterans |
N/A |
N/A |
No information
|
| Interstitial lung diseases |
N/A |
N/A |
No information
|
| Sarcoidosis |
approx 1 in 5,000 or 0.02% or 54,400 people in USA |
54,399 |
20 per 100,000 in the city, less in the country.
|
| pulmonary fibrosis |
N/A |
N/A |
No information
|
| Bronchial disorders |
N/A |
N/A |
No information
|
| Allergic bronchopulmonary aspergillosis |
N/A |
N/A |
No information
|
| Anthrax |
approx 1 in 0 or 0.00% or 0 people in USA |
0 |
0 annual cases notified in USA 1999 (MMWR 1999)
|
| Chlamydia pneumoniae |
N/A |
N/A |
No information
|
| Diphtheria |
approx 1 in 272,000,000 or 0.00% or 1 people in USA |
1 |
1 annual case notified in USA 1999 (MMWR 1999)
|
| Drowning |
approx 1 in 100,000 or 0.00% or 2,720 people in USA |
2,720 |
1 per 100,000 population drowns in Australia 2002 (Australia’s Health 2004, AIHW)
|
| Familial emphysema |
approx 1 in 3,000 or 0.03% or 90,666 people in USA |
90,666 |
1 in 3,000 newborns
|
| High altitude pulmonary edema |
N/A |
N/A |
No information
|
| Lung abscess |
N/A |
N/A |
No information
|
| Lymphangioleiomyomatosis |
N/A |
N/A |
No information
|
| Mesothelioma |
N/A |
N/A |
No information
|
| Mountain sickness |
N/A |
N/A |
No information
|
| Pleural effusion |
N/A |
N/A |
No information
|
| Pleurisy |
N/A |
N/A |
No information
|
| Pneumococcal pneumonia |
approx 1 in 544 or 0.18% or 500,000 people in USA |
499,999 |
500,000 cases annually (NIAID)
|
| Pneumonitis |
N/A |
N/A |
No information
|
| Primary pulmonary hypertension |
approx 1 in 906,666 or 0.00% or 300 people in USA |
299 |
300 new cases annually (NHLBI)
|
| Pulmonary Anthrax |
N/A |
N/A |
No information
|
| Respiratory conditions |
N/A |
N/A |
No information
|
| Respiratory diphtheria |
approx 1 in 100,000,000 or 0.00% or 2 people in USA |
2 |
Approximately 0.001 per 100,000 in USA (DBMD)
|
| Respiratory infections |
N/A |
N/A |
No information
|
| Respiratory syncytial virus |
N/A |
N/A |
No information
|
| Silicosis |
N/A |
N/A |
No information
|
| Stridor |
N/A |
N/A |
No information
|
| Suffocation |
approx 1 in 3,285 or 0.03% or 82,790 people in USA |
82,790 |
1,388 annual cases in Victoria 1996 of suffocation and foreign bodies (DHS-VIC)
|
| Tuberculosis |
approx 1 in 14,814 or 0.01% or 18,360 people in USA |
18,360 |
18,361 cases annually in the USA (1998); 8 million people worldwide develop active TB and 3 million die; 17,531 annual cases notified in USA 1999 (MMWR 1999); 5.50 per 100,000 in Canada 20001
|
| Wheezing |
N/A |
N/A |
No information
|
| Flu |
approx 1 in 3 or 36.00% or 97.9 million people in USA |
97,920,000 |
36 per 100 (NHIS96); 35 million annually up to 50 million annually (NIAID/CDC); 10-20% yearly (NIAID)
|
| Parainfluenza |
N/A |
N/A |
No information
|
| Respiratory failure |
N/A |
N/A |
No information
|
| Pulmonary hypertension |
N/A |
N/A |
No information
|
| Pulmonary edema |
N/A |
N/A |
No information
|
| Pulmonary embolism |
approx 1 in 418 or 0.24% or 650,000 people in USA |
650,000 |
approximately 650,000 cases annually in the USA
|
| Pulmonary thromboembolism |
approx 1 in 418 or 0.24% or 650,000 people in USA |
650,000 |
approximately 650,000 cases annually in the USA
|
| Adult respiratory distress syndrome |
approx 1 in 1,813 or 0.06% or 150,000 people in USA |
150,000 |
150,000 adults (NHLBI)
|
| Respiratory distress syndrome |
N/A |
N/A |
No information
|
| Idiopathic Pulmonary Fibrosis |
N/A |
N/A |
No information
|
| pneumothorax |
N/A |
N/A |
No information
|
| collapsed lung |
N/A |
N/A |
No information
|
| pneumoconiosis |
N/A |
N/A |
No information
|
| Acute Bronchitis |
approx 1 in 21 or 4.60% or 12.5 million people in USA |
12,511,999 |
4.6 per 100 (NHIS96: acute bronchitis); 14.2 million cases annually
|
| Goodpasture syndrome |
N/A |
N/A |
No information
|
The medical term 'incidence' of Lung conditions usually refers
to the annual diagnosis rate of new cases of Lung conditions.
Prevalence is a different medical disease measure that refers
to the estimated population
of people who are managing Lung conditions at any given time (e.g. prevalence includes people who have had
a medical condition for a long time).
For more information on prevalence and incidence statistics, see about prevalence and incidence statistics.
New therapies are improving the survival rates for patients with lung cancer. How do these treatments work?
There are many treatments options available for both small cell and non-small cell lung cancer including surgery, radiation and chemotherapy. Find...
Lung Cancer, the leading cause of cancer death for both men and women in the US, will be diagnosed in over 169,000 people this year. Avoiding tobacco...
Surgery and radiation are the standard treatments for early-stage lung cancer. Now there's evidence chemotherapy may have a role, too. Listen as...